News

The new facility will utilize 100% disposable equipment for manufacturing biologics drug substances. WuXi AppTec chairman and CEO Ge Li said the establishment of the cGMP biologics facility

The tablet, which is the AB-rated generic equivalent of Nordette, is a  Levonorgestrel and Ethinyl estradiol combined oral contraceptive used to prevent pregnancy. Kurvelo tablets are being marketed

The recommendation requires to be ratified by decision of the European Commission which is expected within the next 74-90 days and if approved Betmigatm will be a new

The TOURMALINE-AL1 multi-centre study will assess once-weekly oral MLN9708, a proteasome inhibitor, in combination with dexamethasone. Millennium chief medical officer Karen Ferrante said, "The MLN9708 amyloidosis trial employs

The multi-centre, open-label, early stopping design study will measure the clinical activity of Tasquinimod by the section of patients with progression free survival at pre-defined time-points. Ipsen R&D

Australian-based Dynamiclear’s product is intended for symptomatic treatment of cold sores and fever blisters in just one application. A 150 patient-based clinical trial showed that by day three

Gonax is designed to inhibit the binding of GnRH, a hormone produced by the hypothalamus in the brain, to the specific receptors thereby restraining the testosterone production and

The European Commission is yet to approve the product that should be used in combination with a clinical evaluation. Amyvid global brand leader Diane Bakaysa said, "If approved

Under the LOI, Abattis has gained rights to acquire the area of BC to a BioPharma license and the Vertical Design’s equipment. Abattis president and CEO Mike Withrow